# Journey Medical Corp (DERM)

- Sector: Healthcare · Industry: Drug Manufacturers Specialty and Generic
- SEC CIK: 0001867066 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001867066))
- Full page: https://inspectstocks.com/stocks/derm
- Data as of: price 2026-09-28; newest filing used 2026-08-12; latest fiscal period ended 2026-06-30

## Grade

**C-** on the growth-and-cash rubric, 3 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | passed | $68.2M | $61.5M |
| Revenue growing recently | passed | $68.2M | $61.9M |
| Free cash flow positive | failed | -$24.1M |  |
| Free cash flow growing overall | passed | -$24.1M | -$33.5M |
| Free cash flow growing recently | failed | -$24.1M | $240K |

Business quality (the + / − mark): 1 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -9.0% |  |
| Healthy profit margin | failed | -9.0% |  |
| Strong operating margin | failed | -4.4% |  |
| Good return on equity | failed | -19.2% |  |
| Debt under control | passed | 0.80 |  |
| Turns sales into cash | failed | 0.4% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $68.2M |
| Net income, trailing twelve months | -$6.1M |
| Free cash flow, trailing twelve months | -$24.1M |
| Net margin | -9.0% |
| Operating margin | -4.4% |
| Return on equity | -19.2% |
| Debt to equity | 0.80 |
| Diluted EPS, trailing twelve months | -$0.22 |
| Share price | $6.43 |
| Market value | $176M |
| Price / sales | 2.6x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/derm)
- [Financial statements](https://inspectstocks.com/stocks/derm/financials)
- [Competitors](https://inspectstocks.com/stocks/derm/peers)
- [Earnings](https://inspectstocks.com/stocks/derm/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.